logo

Spark Therapeutics (ONCE)



Trade ONCE now with
  Date
  Headline
5/22/2018 2:02:30 AM Spark Therapeutics And Pfizer Announce Data From 15 Participants With Hemophilia B
5/9/2018 9:43:20 AM Wedbush Is Cutting Spark Therapeutics (ONCE) FY18 Rev. Estimate To 72.6 M From 239.5 M
5/9/2018 9:43:08 AM Wedbush Is Lowering Spark Therapeutics (ONCE) Q4 18 Rev. Estimate To 8.7 M From 16.4 M
5/9/2018 9:42:55 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q3 18 Rev. Estimate To 40.1 M From 48.1 M
5/9/2018 9:42:38 AM Wedbush Is Lowering Spark Therapeutics (ONCE) Q2 18 Rev. Estimate To 8.1 M From 150.4 M
5/9/2018 9:42:13 AM Wedbush Is Lowering Spark Therapeutics (ONCE) FY18 Estimate To -2.55 From -1.76
5/9/2018 9:41:58 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q4 18 Estimate To -1.62 From -1.53
5/9/2018 9:41:35 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q3 18 Estimate To -0.76 From -0.66
5/9/2018 9:41:13 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q2 18 Estimate To 1.08 From 1.68
5/9/2018 9:40:38 AM Wedbush Reiterates Spark Therapeutics (ONCE) At Underperform With $40 Price Target
5/8/2018 7:36:11 AM Spark Therapeutics Q1 Net Loss Applicable To Common Stockholders $46.4 Mln Or $1.25/Shr
4/30/2018 7:31:53 AM Spark Therapeutics Sells Priority Review Voucher For $110 Mln
2/21/2018 7:56:12 AM Wedbush Is Increasing Spark Therapeutics (ONCE) FY18 Rev. Estimate To 239.5 M From 213.3 M
2/21/2018 7:55:48 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q3 18 Rev. Estimate To 48.1 M From 41.1 M
2/21/2018 7:55:37 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q2 18 Rev. Estimate To 150.4 M From 140.8 M
2/21/2018 7:55:26 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q1 18 Rev. Estimate To 24.6 M From 15.0 M
2/21/2018 7:55:04 AM Wedbush Is Increasing Spark Therapeutics (ONCE) FY19 Estimate To -1.76 From -2.30
2/21/2018 7:54:33 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q4 18 Estimate To -1.53 From -1.51